Table 1.
Characteristics of the patients at baseline.
| Characteristics of Patients | PHBE Patch Group (N = 6) |
Reference Product Group (N = 6) |
Total Patients (N = 12) |
|---|---|---|---|
| Demographics | |||
| Median age (interquartile range)—year | 86 (80–93) | 75 (51–90) | 80 (51–93) |
| Gender—% | |||
| Male | 66.7 | 83.3 | 75.0 |
| Female | 33.3 | 16.7 | 25.0 |
| Body mass index—% | |||
| >25 (overweight) | 33.3 | 50 | 41.7 |
| <25 (healthy weight) | 66.7 | 50 | 58.3 |
| Fitzpatrick skin type—% | |||
| I | 16.7 | 33.3 | 25.0 |
| II | 50.0 | 33.3 | 41.7 |
| III | 33.3 | 33.3 | 33.3 |
| Unprotected sun exposure—% | 100.0 | 83.3 | 91.7 |
| Current Smoker—% | 0.0 | 16.7 | 8.3 |
| Characteristics of non-melanoma skin cancer (NMSC) | |||
| Cancer type—% | |||
| Basal cell carcinoma (BCC) | 50.0 | 50.0 | 50.0 |
| Squamous cell carcinoma (SCC) | 33.3 | 16.7 | 25.0 |
| Basosquamous carcinoma (BSC) | 16.7 | 33.3 | 25.0 |
| Tumor size (cm2)—% | |||
| >20 | 50.0 | 50.0 | 50.0 |
| <20 | 50.0 | 50.0 | 50.0 |
| Primary—% | 83.3 | 50.0 | 66.7 |
| Recurring—% | 16.7 | 50.0 | 33.3 |
| Surgery—% | 100.0 | 66.7 | 83.3 |
| Radiation therapy (RT) | |||
| Total dose (cGy)—% | |||
| 5750 | 50.0 | 16.7 | 33.3 |
| 5500 | 33.3 | 66.7 | 50.0 |
| 4800 | 16.7 | 16.7 | 16.7 |
| Fraction dose (cGy)—% | |||
| 250 | 66.7 | 50.0 | 58.3 |
| 200/400 1 | 16.7 | 0.0 | 8.3 |
| 250/300 1 | 16.7 | 16.7 | 16.7 |
| 250/308 1 | 0.0 | 16.7 | 8.3 |
| 300/400 1 | 0.0 | 16.7 | 8.3 |
| Fractions—% | |||
| 15 | 0.0 | 16.7 | 8.3 |
| 22 | 33.3 | 66.7 | 50.0 |
| 23 | 66.7 | 16.7 | 41.7 |
1 Combination of fraction doses.